The PTGS2 protein level is modulated by beta-2 adrenergic receptor (ADRB2) receptor signaling, and PTGS2 silencing suppresses migration and invasion of ovarian cancer cells [36]. Here, ADRB2 is linked to ovarian carcinoma.